MoneyWorks4Me

Lupin - Quaterly Results

07 Feb 2024 Evaluate
The sales for the December 2023 quarter moved up 43.85% to Rs. 41157.50 millions as compared to Rs. 28611.10 millions during the corresponding quarter last year.The company almost doubled its revenue to Rs. 9164.40 millions  from Rs. 404.00 millions in the quarter ended December 2023.Operating Profit saw a handsome growth to 12405.00 millions from 2322.30 millions in the quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 41157.50 28611.10 43.85 112706.20 84225.60 33.81 112588.30 117716.70 -4.36
Other Income 231.60 222.10 4.28 765.00 440.60 73.63 912.60 1504.20 -39.33
PBIDT 12405.00 2322.30 434.17 28341.00 8564.40 230.92 11739.20 4261.30 175.48
Interest 113.60 307.50 -63.06 428.60 690.00 -37.88 984.40 734.70 33.99
PBDT 12291.40 2014.80 510.06 27912.40 7874.40 254.47 10754.80 3526.60 204.96
Depreciation 1451.80 1340.30 8.32 4347.10 4021.40 8.10 5483.40 5141.90 6.64
PBT 10839.60 674.50 1507.06 23565.30 3853.00 511.61 5271.40 -1615.30 -426.34
TAX 1675.20 270.50 519.30 4145.20 791.00 424.05 1019.30 271.70 275.16
Deferred Tax -170.90 142.90 -219.59 -4.70 86.30 -105.45 60.40 -306.30 -119.72
PAT 9164.40 404.00 2168.42 19420.10 3062.00 534.23 4252.10 -1887.00 -325.34
Equity 910.70 909.60 0.12 910.70 909.60 0.12 910.00 909.00 0.11
PBIDTM(%) 30.14 8.12 271.33 25.15 10.17 147.29 10.43 3.62 188.03
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..